BioLine Rx Ltd logo

BioLine Rx Ltd - ADR

NEW
STU:YP2 (Israel)   ADR
€ 2.5 +0.10 (+4.17%) Jul 15
N/A
P/B:
0.79
Market Cap:
€ 10.88M ($ 12.46M)
Enterprise V:
€ 7.29M ($ 8.35M)
Volume:
458.00
Avg Vol (2M):
329.00
Trade In:

BioLine Rx Ltd (STU:YP2) Dividend

BioLine Rx Ltd (STU:YP2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -41.4%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:YP2 Dividend

Does BioLine Rx Ltd (STU:YP2) pay a dividend?

BioLine Rx Ltd (STU:YP2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BioLine Rx Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BioLine Rx Ltd has returned capital to shareholders via buybacks at a rate of -41.4% over the past 3 years.

What are dividend-paying alternatives to BioLine Rx Ltd?

For dividend-paying alternatives in BioLine Rx Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.